Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 28, 2020

SELL
$215.77 - $276.76 $76 Million - $97.4 Million
-352,089 Closed
0 $0
Q2 2020

Jul 16, 2020

SELL
$219.9 - $263.41 $28.2 Million - $33.8 Million
-128,190 Reduced 26.69%
352,089 $84.2 Million
Q1 2020

Apr 30, 2020

BUY
$195.69 - $279.01 $808,395 - $1.15 Million
4,131 Added 0.87%
480,279 $110 Million
Q4 2019

Jan 23, 2020

BUY
$236.45 - $266.82 $113 Million - $127 Million
476,148 New
476,148 $129 Million
Q4 2019

Jan 22, 2020

SELL
$236.45 - $266.82 $119 Million - $134 Million
-502,711 Closed
0 $0
Q3 2019

Oct 29, 2019

SELL
$230.58 - $256.08 $3.19 Million - $3.54 Million
-13,840 Reduced 2.68%
502,711 $127 Million
Q2 2019

Jul 17, 2019

BUY
$217.4 - $246.08 $7.03 Million - $7.96 Million
32,341 Added 6.68%
516,551 $130 Million
Q1 2019

Apr 18, 2019

BUY
$206.05 - $248.17 $712,314 - $857,923
3,457 Added 0.72%
484,210 $121 Million
Q4 2018

Jan 14, 2019

BUY
$204.73 - $257.93 $753,406 - $949,182
3,680 Added 0.77%
480,753 $108 Million
Q3 2018

Oct 04, 2018

BUY
$233.07 - $256.0 $4.71 Million - $5.17 Million
20,210 Added 4.42%
477,073 $125 Million
Q2 2018

Aug 22, 2018

BUY
$208.1 - $233.85 $95 Million - $107 Million
456,623 Added 190259.58%
456,863 $0
Q2 2018

Aug 21, 2018

SELL
$208.1 - $233.85 $93.7 Million - $105 Million
-450,272 Reduced 99.95%
240 $457,000
Q1 2018

Apr 06, 2018

BUY
$205.46 - $240.27 $3.72 Million - $4.35 Million
18,124 Added 4.19%
450,512 $97.6 Million
Q4 2017

Jan 10, 2018

BUY
$189.0 - $222.64 $6.76 Million - $7.97 Million
35,776 Added 9.02%
432,388 $92.6 Million
Q3 2017

Oct 12, 2017

BUY
$186.89 - $198.9 $74.1 Million - $78.9 Million
396,612
396,612 $77.7 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $70.6B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Waverton Investment Management LTD Portfolio

Follow Waverton Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waverton Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Waverton Investment Management LTD with notifications on news.